Founded in 1980, family-owned and operated LNK International, Inc. manufactures over-the-counter solid- and liquid-dose pharmaceuticals from multiple facilities in Hauppauge, New York. The company produces more than 170 formulas and works with retail customers on store-brand programs, including proprietary formula development and product launches.
Current Good Manufacturing Practices (cGMP)
Compliance program
Current Good Laboratory Practices (cGLP)
Compliance program
GMP
Quality certification
GLP
Quality certification
Contract Pharmacal CorpContract Pharmacal Corp. is a Wolf family-founded company that has been advancing pharmaceutical development since opening its doors in 1971. From its Long Island base, the company works with pharmaceutical brands, retailers, and wholesalers to develop and manufacture solid-dose medicines and supplements, with services extending from formulation through packaging.HAUPPAUGE, NY
PL DevelopmentsFounded in 1988 by Mitch Singer and Mort Rezack, PL Developments makes, packages and distributes store-brand over-the-counter medicines and consumer healthcare goods. Still family-owned under Singer and his sons, the company has grown from a small private-label operation into a 1,600-plus-employee business with more than 2 million square feet of pharmaceutical facilities. PLD is particularly distinctive for operating the only FDA-approved nicotine chewing-gum facility in the United States, alongside newer nutritional and OTC gummy production.WESTBURY, NY
Jerome Stevens Pharmaceuticals, IncFamily owned and operated since 1979, Jerome Stevens Pharmaceuticals manufactures prescription tablet and capsule formulations in the United States. The company moved from vitamins and over-the-counter preparations into prescription medicines in 1987, and in 2000 became the first company to receive FDA approval for a branded levothyroxine product, Unithroid®. Today, it continues to emphasize product quality over volume while producing billions of tablets.BOHEMIA, NY
Prodose IncProdose develops and manufactures private-label OTC and nutraceutical products, pairing bulk production in India with final packaging and distribution from its 106,000-square-foot facility in Ronkonkoma, New York. Its vertically integrated model is backed by Softgel Healthcare Pvt. Ltd., which produces more than 2 billion softgels annually, while Prodose’s U.S. team handles formulation, regulatory work, packaging, and logistics. The company is particularly distinctive for its proprietary Gummesules gummy-softgel technology and its focus on taking health products from concept to retail shelf.RONKONKOMA, NY